Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × liposomal doxorubicin × Clear all

NCT01736943 2021-02-24

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Phase 2 Completed

25 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute